(Q72956784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy. The Granisetron Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

0 references

I E Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

350-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01208844

30 October 2019

exact match

0 references

cites work

Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group

1 reference

12 December 2020

Extrapyramidal reactions with high-dose metoclopramide

1 reference

12 December 2020

A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group

1 reference

12 December 2020

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist

1 reference

12 December 2020

Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy

1 reference

12 December 2020

The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis.

1 reference

12 December 2020

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism

1 reference

12 December 2020

Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research

1 reference

12 December 2020

The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.

1 reference

12 December 2020

The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01208844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8383688%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference